Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
09/19/1994 | CA2119161A1 Bacterial plasmid shuttle vectors for streptomycetes and escherichia coli |
09/16/1994 | CA2118824A1 Expression of pertussis holotoxin in bordetella pertussis |
09/15/1994 | WO1994020641A1 Methods for diagnosis and treatment of xscid |
09/15/1994 | WO1994020639A1 Over expession of single-stranded molecules |
09/15/1994 | WO1994020636A1 Genetically engineered enzymes and their conjugates for diagnostic assays |
09/15/1994 | WO1994020634A1 Esterase and its use in biotransformation |
09/15/1994 | WO1994020631A2 Production of glycolate oxidase in methylotrophic yeast |
09/15/1994 | WO1994020630A1 Dna construct and method of detecting protein kinase c inhibitors using the dna construct |
09/15/1994 | WO1994020629A1 Eukaryotic expression vectors driven by a myosin heavy chain gene promoter |
09/15/1994 | WO1994020628A2 Improved feedcrops enriched in sulfur amino acids and methods for improvement |
09/15/1994 | WO1994020627A1 Mannose or xylose based positive selection |
09/15/1994 | WO1994020626A1 Acetobacter, plasmid originating therein, and shuttle vector constructed from said plasmid |
09/15/1994 | WO1994020625A1 Method for inducing tumor cell death |
09/15/1994 | WO1994020624A1 Prohormone convertase transformed cells and polypeptide synthesis |
09/15/1994 | WO1994020623A1 Cloning and recombinant production of vespid venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon |
09/15/1994 | WO1994020622A1 Polypeptide fragment capable of inducing neutralising antibodies against feline immuno-deficiency virus |
09/15/1994 | WO1994020621A2 Proteinaceous particles containing retroviral element |
09/15/1994 | WO1994020620A2 Cloning of the zymocin gene and use of zymocin in beverages |
09/15/1994 | WO1994020619A1 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T-CELL ACTIVATION AND PROLIFERATION |
09/15/1994 | WO1994020618A1 Genetic suppressor elements associated with sensitivity to chemotherapeutic drugs |
09/15/1994 | WO1994020617A2 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
09/15/1994 | WO1994020616A1 Colon mucosa gene having down-regulated expression in colon adenomas and adenocarcinomas |
09/15/1994 | WO1994020615A1 Bone stimulating factor |
09/15/1994 | WO1994020614A1 Allergenic protein and peptides from house dust mite and uses therefor |
09/15/1994 | WO1994020613A1 Detection of malaria |
09/15/1994 | WO1994020612A1 An enzyme with rhamnogalacturonase activity |
09/15/1994 | WO1994020611A1 An enzyme with arabinanase activity |
09/15/1994 | WO1994020610A1 Variants of bile salt-stimulated lipase, dna molecules encoding them, and transgenic non-human mammals |
09/15/1994 | WO1994020608A1 Improved vectors for gene therapy |
09/15/1994 | WO1994020605A1 ANIMAL 2-5A-DEPENDENT RNases AND ENCODING SEQUENCES THEREFOR |
09/15/1994 | WO1994020604A2 Agricultural-chemical-producing endosymbiotic microorganisms and method of preparing and using same |
09/15/1994 | WO1994020539A1 Method and compositions for recombinant osteogenic protein production |
09/15/1994 | WO1994020537A1 Non-glycosylated tfpi analogues |
09/15/1994 | WO1994020535A1 ECOTIN AS A FACTOR Xa, XIa, AND XIIa INHIBITOR |
09/15/1994 | WO1994020529A1 Osteogenic growth oligopeptides and pharmaceutical compositions containing them |
09/15/1994 | WO1994020522A1 Oligodendroglial trophic factor and methods of use thereof |
09/15/1994 | WO1994020517A1 Gene transfer for treating a connective tissue of a mammalian host |
09/15/1994 | WO1994020146A1 Recombinant adenoviruses and use thereof in gene therapy for treating eye diseases |
09/15/1994 | WO1994020138A1 Recombinant epstein-barr virus protein and its use in vaccine |
09/15/1994 | WO1994020137A1 Production of human papillomavirus capsid protein and virus-like particles |
09/15/1994 | WO1994020135A1 Vaccines expressed in plants |
09/15/1994 | WO1994020128A1 Therapeutic uses of bactericidal/permeability increasing protein products |
09/15/1994 | WO1994020113A1 The human c/ebp gene and vectors for its expression |
09/15/1994 | WO1994020079A1 Human brain phosphodiesterase |
09/15/1994 | WO1994019945A1 Oligonucleotide therapies for modulating the effects of herpesviruses |
09/15/1994 | WO1994019935A1 Isolation of components of interest from milk |
09/15/1994 | WO1994017192A3 Lysosomal targeting of immunogens |
09/15/1994 | WO1994017091A3 Foldback triplex-forming oligonucleotides |
09/15/1994 | WO1994013822A3 Methods for stable transformation of wheat |
09/15/1994 | WO1994011510A3 Modulators of hematopoietic progenitor cells |
09/15/1994 | WO1994010315A3 Process for enhancing the content of a selected amino acid in a seed storage protein |
09/15/1994 | WO1994004688A3 Cationic peptides and method for production |
09/15/1994 | CA2654420A1 Cloning and recombinant production of vespid venom enzymes, such as phospholiphase and hyaluronidase, and immunological therapies based thereon |
09/15/1994 | CA2158037A1 Oligodendroglial trophic factor and methods of use thereof |
09/15/1994 | CA2157931A1 Improved vectors for gene therapy |
09/15/1994 | CA2157901A1 Bone stimulating factor |
09/15/1994 | CA2157782A1 Gene transfer for treating a connective tissue of a mammalian host |
09/15/1994 | CA2157770A1 Genetic suppressor elements associated with sensitivity to chemotherapeutic drugs |
09/15/1994 | CA2157767A1 Genetically engineered enzymes and their conjugates for diagnostic assays |
09/15/1994 | CA2157589A1 The human c/ebp gene and vectors for its expression |
09/15/1994 | CA2157010A1 Method for inducing tumor cell death |
09/15/1994 | CA2156719A1 Recombinant epstein-barr virus protein and its use in vaccine |
09/15/1994 | CA2154355A1 Recombinant virus and their use in gene therapy |
09/15/1994 | CA2152779A1 Esterase and its use in biotransformation |
09/15/1994 | CA2135307A1 Animal 2-5a-dependent rnases and encoding sequences therefor |
09/14/1994 | EP0614989A1 A method for in vivo selection of ligand-binding proteins |
09/14/1994 | EP0614988A1 Method of identifying fast-hybridizing single-stranded polynucleotides |
09/14/1994 | EP0614985A1 Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type I (HIV-1) GP120 and methods of use |
09/14/1994 | EP0614982A1 Recombinant vector for the exocellular preparation of single chain antibodies expressed in bacillus subtilis |
09/14/1994 | EP0614981A1 Chimeric human interferon-gamma-receptor/immunoglobulin polypeptides |
09/14/1994 | EP0614980A1 TAT transdominant variants from human Immunodeficiency virus |
09/14/1994 | EP0614979A1 Hog cholera virus vaccine and diagnostic |
09/14/1994 | EP0614978A1 Soluble human Fcgamma receptors, method to prepare them, pharmaceutical compositions containing them, their use as drugs and their diagnostic use |
09/14/1994 | EP0614977A2 Huntingtin DNA, protein and uses thereof |
09/14/1994 | EP0614976A2 Mammalian influx peptide transporter |
09/14/1994 | EP0614975A1 Glycoprotein hormone receptor molecules |
09/14/1994 | EP0614974A2 Bone - associated transcription control factor-like protein and process for producing the same |
09/14/1994 | EP0614973A1 Polypeptide useful in diagnosis of coccidia infection and recombinant-DNA methods for manufacturing same |
09/14/1994 | EP0614969A2 Use of Herpes saimiri transformed lymphocytes in a process of multiplication of immune deficiency inducing virus of the HIV type |
09/14/1994 | EP0614672A1 Biocompatible medical devices |
09/14/1994 | EP0614531A1 Process for detecting p53-specific antibodies |
09/14/1994 | EP0614492A1 In situ hybridization method. |
09/14/1994 | EP0614491A1 Transcription adaptors in eukaryotes |
09/14/1994 | EP0614490A1 Production of proteins using 7b2 protein |
09/14/1994 | EP0614489A1 NOVEL HUMAN cdc25 GENES, ENCODED PRODUCTS AND USES THEREFOR |
09/14/1994 | EP0614488A1 Recombinant vaccine against lyme disease |
09/14/1994 | EP0614487A1 Dna encoding a glycine transporter and uses thereof |
09/14/1994 | EP0614486A1 Targeted delivery of virus vector to mammalian cells |
09/14/1994 | EP0614465A1 HYBRID PROTEIN BETWEEN CS FROM PLASMODIUM AND HBsAG |
09/14/1994 | EP0614374A1 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES |
09/14/1994 | EP0575528A4 Response element compositions and assays employing same |
09/14/1994 | EP0542761B1 Eliminating internal initiation of soluble cd4 gene |
09/14/1994 | EP0511221B1 Process for enriching or cleaning hirudin |
09/14/1994 | EP0432162B1 Apparatus and method for automated separation of extra-chromosomal dna from a cell suspension |
09/14/1994 | EP0424405B1 Variants of plasminogen activators and processes for their production |
09/14/1994 | EP0414887B1 Spin filter for removing substantially cell-free culture medium from suspension cell culture system |
09/14/1994 | CN1092106A Phytohormone-independent cell culture |
09/14/1994 | CN1091955A Hematopoietic facilitatory cells |
09/14/1994 | CN1025920C Electricity transferring device for cell electric fusion |
09/13/1994 | US5347076 Herbicide-tolerant plants expressing carbamate hydrolase |